Fingerprint
Dive into the research topics of 'Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically